BBTV

About Us

all episodes

Stem Cells at a Glance – Stem Cell Review (EP1)

scr-ep1
  1. Different Types of Stem Cells & Future Medical Applications
  2. Stem Cell Interaction and the iPS Cell Revolution
  3. The Business & Politics of Stem Cells

Allogeneic or Autologous? – Stem Cell Review (EP2)

scr-ep2
  1. Technology & Business Models
  2. Intellectual Property
  3. Regulatory Concerns
  4. Transplantation & Immune Rejection

Biological Processes & Industrial Production – Stem Cell Review (EP3)

scr-ep3
  1. Biological Processes
  2. Cancer Stem Cells
  3. Industrial Production

Tools for Drug Screening – Stem Cell Review (EP4)

scr-ep4
  1. Disease Models
  2. Disease Models
  3. In Vitro Clinical Trials
  4. Case Study – Spino Muscular Atrophy
  5. Disease in a Dish to Personalized Medicine

Looking Forward to 2015 – Stem Cell Review (EP5)

scr-ep5
  1. Introduction by Bill Kridel
  2. George Q. Daley, M.D., Ph.D. – Harvard Medical School, Children’s Hospital Boston
  3. Dr. Ronald D.G. McKay – NIH, NINDS (National Institute of Neurological Disorders and Stroke)
  4. Dan Marshak Ph.D. – PerkinElmer, Inc.
  5. Rudolf Jaenisch, M.D. – MIT (Massachusetts Institute of Technology)
  6. John Sinden, Ph.D. – ReNeuron Group
  7. Alan O. Trounson, Ph.D. – CIRM (California Institute for Regenerative Medicine)
  8. Alan Colman, Ph.D., M.A. – A*STAR Institute of Medical Biology, Singapore Stem Cell Consortium (SSCC)
  9. John Walker – iPierian
  10. Shinya Yamanaka, M.D., Ph.D. – UCSF and Kyoto University
  11. Irving L. Weissman, M.D – Stanford University
  12. David T. Scadden, M.D. – Harvard Medical School, Harvard Stem Cell Institute, Massachusetts General Hospital
  13. Gregory A. Bonfiglio – Proteus Venture Partners
  14. Closing Remarks by Bill Kridel

Mesenchymal Stem Cells and Connective Disorders – Stem Cell Review (EP6)

scr-ep6
  1. Mesenchymal Stem Cells and Connective Disorders by Gordana Vunjak-Novakovic
  2. Angioblast, Mesoblast, and the Medical Applications of Mesenchymal Precursor Cells

Neural Stem Cells and CNS Disorder – Stem Cell Review (EP7)

scr-ep7
  1. Neural Stem Cells and CNS Disorder with Evan Snyder
  2. StemCells Inc. using Neural Stem Cells for their Neuroprotective Effect
  3. Q Therapeutics and the Role of Neuronal Support Cells

Stem Cells & Diabetes – Stem Cell Review (EP8)

scr-ep8
  1. Stem Cells & Diabetes with Alan Lewis
  2. Novocell Leading Type-1 Diabetes Stem Cell Research
  3. Pfizer’s Broad Use of Stem Cells, in Search of New Cures

Autoimmune Diseases & Blood Disorders – Stem Cell Review (EP9)

scr-ep9
  1. AutoImmune Diseases & Blood Disorders with Hanna Mikkola
  2. Celgene Derives Stem Cells from the Placenta
  3. Fate Therapeutics Modulates Cell Fate

Tissue Repair – Stem Cell Review (EP10)

scr-ep10
  1. Tissue Repair with Bob Langer
  2. Organogenesis’ Apligraf: Allogeneic Cell Based Wound Healing; FDA Approved and Shipping!

  • Best of the Web

    • Alzheimer's Disease
    • Antibiotic Resistance
    • Cancer Immunotherapy
    • Cell Therapy
    • Hepatitis C
    • LOL
    • Stem Cells
    • - View All -

  • Series

    • The Stem Cell Review
    • Cancer Immunotherapy

  • Shows

    • Biotech in the Money
    • Wall Street On BBTV
    • Science Breakthrough
    • The Jan Buck Show
    • Special Interview
    • Report on Location

  • Corporate Videos

    • 60sec Pitches
    • Investor Presentations
    • Panorama

  • Store

    • Series Sponsorship
    • Corp. Communications
    • DVDs

  • About the Series


    The Stem Cell Review is a 10-part original series on the science, medical applications, and business of stem cells.


    This program will give you a clear and concise understanding of the state of stem cells today, with the additional depth and expertise you would come to expect from the most renown authorities in the field.


    The Stem Cell Review is a BioBusiness.TV Original Program, presented by Bill Kridel, produced by Jean-Loup Romet-Lemonne and Jonathan Teper.

  • ABOUT BIOBUSINESS.TV
  • BioBusiness.TV is the first independent Internet TV Network for biotechnology professionals. We create and syndicate video-based industry focused shows and series that range from scientific breakthroughs, to equity analyst insights, as well as C-level executive and investor interviews on strategy, management, policy, marketing, science and more. We strive to enhance the quality and accessibility of industry video programming, and to deliver information biotechnology professionals can rely on to make sound and informed decisions.
  • PARTNERING WITH BIOBUSINESS.TV
  • If you’ve got great video programs and a growing audience, let BioBusiness.TV help you take it to the next level through our Partner Program. You can reach out to us through our ‘contact us’ page.
  • DISCLAIMER
  • Viewers should verify all claims and do their own due diligence before investing in any securities mentioned on BioBusiness.TV.
  • COPYRIGHT © 2011 BIO BUSINESS TV, INC. All Rights Reserved